Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2020 / Nov / Expanding Our (Digital) Horizons
Oncology Digital and computational pathology Technology and innovation Oncology Profession Research and Innovations

Expanding Our (Digital) Horizons

Digital pathology: a tool to meet the needs of patients worldwide

By E. Blair Holladay 11/01/2020 1 min read

Share

The technology used in pathology and laboratory medicine has changed exponentially over the past two decades – and it shows no sign of slowing down. With the rise of personalized medicine, the importance of the outcomes of our work – not just running tests as ordered – increases, and these changes become not only needed, but expected. As pathologists and medical laboratory scientists, we are the cornerstone of healthcare, and not to embrace advances that provide better insight into patient needs ultimately means doing a disservice to the patients we serve.

In recent years, digital pathology has emerged as an essential component of how we practice. By incorporating digital pathology into our processes, efficiency has increased and our views have expanded (in some cases literally, when whole-slide imaging comes into play). Digital pathology lets us move our work beyond our own laboratories and healthcare organizations. It allows us to reach more patients – both in our own backyard and on the other side of the world.

In 2015, digital pathology allowed us the opportunity to reduce the suffering and death that so often follows a cancer diagnosis. ASCP expanded the reach of patient care by launching Partners for Cancer Diagnosis and Treatment in Africa. This ASCP-led coalition brought much needed leapfrog technology to sub-Saharan Africa, where in-continent pathologists and medical laboratory scientists could now connect with colleagues in America for rapid diagnosis. The ability to impact so many lives through digital technology is something we at ASCP have both appreciated and embraced since that launch – and something we are committed to continuing.

Even throughout the COVID-19 pandemic, we have been able to care for patients in resource-limited countries, thanks in large part to digital pathology. Recent equipment donations from our members to laboratories in Zambia (1), for example, have enabled pathologists there to get second opinions from local and international subspecialists, which the country lacks. The direct access to renal, neuro-, and dermatopathologists using digital technologies has helped improve patient care despite the global crisis.

As pathologists and medical laboratory scientists, embracing advances that make us better is not a choice – it is a must. If we want to progress in research and in our profession, developments like digital pathology will help us get there. If we want to make a difference in and improve patient care, it is this forward motion that will save lives.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. ASCP, “Undaunted by the Pandemic, ASCP Continues to Support Diagnosis of Cancer Patients in Africa” (2020). Available at: https://bit.ly/34twLxU.

About the Author(s)

E. Blair Holladay

CEO of the American Society for Clinical Pathology

More Articles by E. Blair Holladay

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Global Referral
Digital and computational pathology
Global Referral

January 12, 2024

10 min read

How digital pathology is transforming the delivery of remote second opinions

Cracking Colon Cancer
Digital and computational pathology
Cracking Colon Cancer

January 25, 2024

1 min read

How a new clinically approved AI-based tool enables rapid microsatellite instability detection

The (Pathology) IT Crowd?
Digital and computational pathology
The (Pathology) IT Crowd?

December 30, 2021

5 min read

The pathologist’s guide to IT considerations for digitization

Defining the Next Generation of NGS
Digital and computational pathology
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.